This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations in Medical Research: The Contributions of Taraneh K Sadeghi
Introduction
Taraneh K Sadeghi is a notable inventor based in Houston, Texas. She has made significant contributions to the field of medical research, particularly in understanding and combating opportunistic mold infections. Her work is crucial for developing new antifungal agents and improving patient outcomes.
Latest Patents
Sadeghi holds a patent for a groundbreaking invention titled "Large animal model of invasive pulmonary aspergillosis in an immunocompromised host." This model was established using a beagle dog that was rendered immunosuppressed through total body irradiation and daily steroids. The model allows for the successful inoculation of mold through a bronchoscope, leading to a localized infection that can be studied in detail. This invention aims to enhance the understanding of the pathophysiology of mold infections and facilitate the development of effective antifungal treatments.
Career Highlights
Taraneh K Sadeghi is affiliated with the University of Texas System, where she continues her research and innovation in medical science. Her work has the potential to save patients from ineffective clinical trials by providing a reliable model for testing antifungal drugs.
Collaborations
Sadeghi collaborates with esteemed colleagues such as Borje S Andersson and Douglas M Cromeens. Their combined expertise contributes to advancing research in the field of infectious diseases.
Conclusion
Taraneh K Sadeghi's innovative work in developing a large animal model for studying invasive pulmonary aspergillosis represents a significant advancement in medical research. Her contributions are vital for improving treatment strategies and patient care in the face of opportunistic infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
